'It totally backfired': The pitfalls of Alzheimer's genetic testing

'It totally backfired': The pitfalls of Alzheimer's genetic testing
Lexi Nelson talks to her mother Wendy about her income tax filing at their home in Foxborough, Massachusetts, US, on March 21, 2023. Wendy Nelson's mother died from Alzheimer's disease, her father suffers from it, and genetic tests show that Wendy carries two APOE4 gene variants, and her three daughters each carry one APOE4 gene variant, indicating an increased risk of Alzheimer's disease.
PHOTO: Reuters

CHICAGO - Wendy Nelson watched her mother slowly die of Alzheimer's disease, unable to move or swallow at the end. "All her pleasures of life were gone," Nelson said.

Grief-stricken, terrified of facing the same death, Nelson ordered 23andMe DNA test kits for Christmas 2020 for herself and three adult daughters.

A Boston-based biotech executive who is now 52, Nelson hoped the kits would provide reassurance. They delivered the worst possible result. Nelson has two copies of the APOE4 gene variant that increases the risk of Alzheimer's, which means her risk of developing the disease is eight to 12 times higher than people with the most common version of APOE.

"It totally backfired," she said.

Millions of Americans are expected to test for Alzheimer's in the coming years - some like Nelson, with at-home test kits, others at labs, as new drugs for people with early Alzheimer's from partners Eisai Co Ltd and Biogen Inc and Eli Lilly and Co usher in sweeping change in approaches to treatment of the disease.

Testing for the APOE4 gene variant among Americans being treated for Alzheimer's has more than doubled from a year ago, an exclusive analysis of medical records for Reuters by health data firm Truveta found. 

The increase was driven by the new treatments that promise to slow the progression of the disease, but also carry risks, especially for people like Nelson carrying two copies of APOE4.

Yet few support services are available to help people deal with the implications of APOE4 testing, according to interviews with more than a dozen neurologists and genetic counsellors. Alzheimer's patients and caregivers face a shortage of genetic counsellors to explain the tests and help them navigate the psychological, medical, financial and legal consequences.

Eisai and Biogen's Leqembi, which arrived on the market in January, costs USD$26,500 (S$35,380) a year and is not covered by Medicare outside of clinical trials. Medicare has said it will expand coverage if the drug is granted full US approval, expected this summer.

"When you learn that information, you're potentially learning information about your siblings, about your children," said Emily Largent, a bioethicist and health policy expert at the University of Pennsylvania Perelman School of Medicine.

"People describe feeling existential dread."

Read Also
Rare success for Alzheimer's research unlocks hope for future therapies
world
Rare success for Alzheimer's research unlocks hope for future therapies

As a scientist, Nelson understood intellectually what her APOE4 results meant, but they created emotional havoc for her family.

She had inherited one copy of APOE4 from her mother and the other from her father, who was showing no symptoms of Alzheimer's at the time.

When her father's memory began to fail a year later, one of her two sisters doubted it could be Alzheimer's, Nelson said. Nelson knew he had to have the disease, because of her genetic test results.

The tests also showed that each of Nelson's three adult daughters had one copy of APOE4, which triples or quadruples the risk of developing the disease - confronting them with their own Alzheimer's risks along with their mother's.

Nelson's daughter, Lindsey, 22, and a fourth year nursing student at New York University, said she was traumatized when, even before testing, Nelson talked about exploring assisted suicide rather than suffer her mother's fate.

"I would yell at her, cover my ears and run away," Lindsey said. "There are many complicated emotions involved."

Nelson's eldest daughter, Lexi, 24, who works in data analytics, turned to research showing that lifestyle changes such as weight lifting can improve cognitive function. "I've tried really hard to improve my sleep, I'm exercising a lot," she said.

Her youngest, Pam, 20, a sophomore biology major at UCLA, said she takes comfort in knowing that her mother's result is not a diagnosis. "It's just a risk factor, and there are many other factors that influence what will happen."

Leqembi is not suitable for Nelson, who is not symptomatic. Even if she were eligible, she said she is not a fan because of the risk of brain swelling, which is higher for people with two copies of APOE4.

Read Also
world
Eisai says Alzheimer's drug succeeds in slowing cognitive decline

Nelson is pinning her hopes on an experimental pill from Alzheon Inc, which is being tested in people with early Alzheimer's who have two copies of APOE4.

She is working her way through a bucket list of trips. In February, she climbed Mt. Kilimanjaro to raise money for a cancer charity, and she would like to visit Patagonia, the Greek Islands, South Africa, possibly Antarctica.

If treatment fails, she said she has her "exit plan": legal euthanasia through a clinic in Switzerland. "I do not want to live the way my mom had to live her last five years of life. She was miserable," she said.

The testing revolution

Until recently, most doctors tended not to order genetic tests to determine Alzheimer's risk, because there were no effective treatments to slow or prevent the disease.

That changed with Leqembi, which was shown to reduce the rate of cognitive decline by 27 per cent in patients with mild Alzheimer's. Eli Lilly's donanemab is in clinical trials with results expected by June.

Both drugs remove the buildup in the brain of amyloid plaques associated with Alzheimer's, and are viewed as a first step towards even more effective treatments. Both can cause swelling and microbleeds in the brain. US regulators recommend genetic testing before starting treatment with Leqembi.

"With this drug, it behooves us to check," said Dr. Sarah Kremen, a neurologist at Cedars-Sinai in Los Angeles.

In the four months ahead of US approval of Leqembi in January, APOE4 testing among people over 55 who visited a doctor within the last 30 days increased 125 per cent. From September 2022 to January 2023, the rate averaged 1.4 tests per 100,000 patients, compared with 0.6 tests per 100,000 patients in the same period a year earlier, the analysis by Seattle-based Truveta found.

The analysis was based on a review of medical records from 7.9 million adults at 28 major US hospital systems. It does not include at-home consumer tests.

The National Institutes of Health estimates up to 25 per cent of people in the United States have one copy of APOE4 and up to 5 per cent have two copies.

Yet there is a shortage of genetic counselors to help families deal with the implications of having two copies of APOE4.

A 2018 study in the European Journal of Human Genetics found the US had just one trained genetic counselor per 82,000 people. The United Kingdom had 1 per 193,500.

Banner Alzheimer's Institute in Phoenix, which is testing Lilly's donanemab, is researching an interactive online platform to deliver APOE results to volunteers being screened for enrollment in the trial.

"We needed a scalable way to warn people about the potential benefits and risks of genetic disclosure," said Dr. Eric Reiman, Banner's director.

While the US Genetic Information Nondiscrimination Act (GINA) bans discrimination in employment and health insurance, it does not cover long-term care and disability and life insurance.

Some members of families with increased genetic risk of Alzheimer's say it might be better not to know at all.

Dovie Bryant, 77, who is taking part in the Lilly trial, lost her mother to Alzheimer's in 2012.

When she shared with her five siblings that she had one copy of the APOE4 variant, none wanted to find out their own status.

Her brother Jim Painter, 71, said he feared testing could make it harder to pass a health screening to move into a retirement community that offers increasing levels of care as a person ages.

"That might be a red flag," Painter said.

Source: Reuters

homepage

trending

trending
    US Judge Frank Caprio, of TikTok fame, dies aged 88
    More Singaporeans find religion has 'considerable influence' in their lives: IPS study
    Tabletop, card games convention TableCon Quest 2025 triples in size as Bushiroad lands in Singapore
    Indonesia minister arrested as part of anti-graft probe, agency says
    MOE reveals timeline of Sengkang Green Primary bullying saga; pupil who sent death threats caned for subsequent incident
    Woman seeking man who helped to save 4-year-old son from drowning in hotel pool
    'Dreams don't expire': Desmond Tan buys first landed home, marks 39th birthday
    $218 release fee: Car park operator at Woodlands VEP centre criticised for clamping cars parked illegally
    Man finds missing bike after 3-hour search in Jurong, warns thief: 'I'll find you next time'
    From island-themed installations to festival villages: What to expect at Singapore Night Festival 2025
    'I saw the driver waving': SMRT bus captain who fought car fire near KKH says he couldn't ignore call for help
    Woman in China buys lottery while taking shelter from rain, wins over $170k

Singapore

Singapore
    • Nearly 80% of visitors to Johor in 2025 were from Singapore, says Malaysian official
    • $1,500 for a 10-minute ride? Grab blames 'temporary system issue' for price glitch
    • Only 4 out of 11 stalls are open: This Bukit Batok food court has been dubbed the 'saddest' in Singapore
    • 'Brave and selfless': SMRT praises bus captain for helping to fight car fire near KKH
    • 'I wasn't used to physical training': Art student on joining police Special Operations Command during NS
    • Alert from courier firm helps HSA uncover drugs, e-vaporisers with etomidate in raids
    • Who's sitting where: Singapore Parliament releases seating arrangements
    • Staff member found with active TB after screening at 2 pre-schools; no children diagnosed so far: CDA
    • FairPrice apologises after worm found in salmon bought from Bedok North outlet
    • Singapore indie cinema The Projector owes over $1.2m to creditors

Entertainment

Entertainment
    • 'I almost became a widow': Ada Choi discusses husband suffering heart attack in Singapore
    • Jack Neo uses AI to create SG60 song and music video that includes Lee Kuan Yew
    • Health alert: Jet Li undergoes surgery, Jackson Wang cancels fan-sign after getting food poisoning
    • K-pop girl group StayC prove they can do more than cute concepts at Singapore concert
    • Morgan Wallen reportedly not participating in 2026 Grammys
    • Tom Cruise almost broke his back, suffered 'separated' finger joints filming Mission: Impossible - The Final Reckoning
    • Wynonna Judd's daughter claims she covered up sexual abuse
    • Dawson's Creek cast to reunite for charity event in September

Lifestyle

Lifestyle
    • Indie darling The Projector announces immediate closure
    • 'Skibidi', 'delulu' and other social media words now found in Cambridge dictionary
    • From froyo to acai: Australian dessert chain Yo-Chi launches first international outlet in Singapore
    • Berry cute: Starbucks Singapore and Mofusand launching second collection on Aug 20
    • Cat A COE prices reach their highest point in almost 2 years in second bidding exercise for August 2025
    • The Projector bows out. And what's next for indie culture in Singapore
    • McDonald's teases BTS TinyTan Happy Meal, here's what we know
    • Largest Four Star clearance sale in Ang Mo Kio has $299 mattresses, up to 90% off sofas and more
    • 'We can't keep afloat anymore': Fluff Bakery to close after 12 years
    • We toured a rare part of Singapore where terrace houses are bigger than the semi-detached units

Digicult

Digicult
    • Singaporean Robert Sim receives one of Wikipedia's highest honours for his work on online platform
    • NDR2025: Govt to study new laws to protect kids from harmful, toxic content online
    • Apple Maps brings 3D landmarks and road-level realism to Singapore
    • The best AI tutor for O-level subjects: ChatGPT, Gemini or The Wise Otter?
    • Vivo X Fold5: A foldable contender with a few class-leading surprises
    • Here's everything in GPT-5 that's new and different than OpenAI's previous AI models
    • Australia regulator says YouTube, others 'turning a blind eye' to child abuse material
    • ZipZap car subscription service launches in Singapore
    • Sony RX1R III brings back the compact full-frame but not the Sony playbook
    • China's Premier Li proposes global AI co-operation organisation

Money

Money
    • Global markets face shaky week ahead as US pressure mounts on Ukraine
    • 6 best cashback credit cards in Singapore (August 2025)
    • Best bank offers in Singapore (August 2025): Limited-edition Stitch charms, 50% off flights and more
    • 9 best personal loans in Singapore with lowest interest rates (August 2025)
    • Best credit card promotions in Singapore (August 2025): Citibank, DBS, HSBC, UOB and more
    • Ninja Van cuts 12% of Singapore workforce after 2 rounds of layoffs in 2024
    • Goh Cheng Liang, Nippon Paint billionaire and richest Singaporean, dies aged 98
    • Singapore upgrades 2025 growth forecast but warns that outlook remains 'clouded by uncertainty'
    • StarHub buys rest of MyRepublic's broadband business in $105m deal; comes after Simba buys M1
    • Keppel to sell M1 unit's telco business to Simba for $1.43b

Latest

Latest
  • Zelenskiy says he wants 'strong' US reaction if Putin not ready to meet
  • Russia needs a nuclear shield update due to 'colossal threats', nuclear chief says
  • Daily roundup: Jack Neo uses AI to create SG60 song and music video that includes Lee Kuan Yew — and other top stories today
  • Thailand's Shinawatra dynasty faces triple court test that could upend politics
  • China's Tibet marks anniversary with songs, dances, reminders of Party's rule
  • Netanyahu escalates attack on Australia's Albanese as Jewish group urges calm
  • Member of Irish rap group Kneecap appears at UK court on terrorism charge
  • UN chief urges immediate Gaza ceasefire, warns of casualties from Israeli operation
  • Trump can end deportation protections for 60,000 immigrants, appeals court says

In Case You Missed It

In Case You Missed It
  • Van driver in Malaysia arrested for dropping off school kids while vehicle was still moving
  • Malaysian teachers caught vaping on school grounds may face fines, up to 2 years' jail
  • Shoelace to tie umbilical cord: Woman in Malaysia goes into labour by roadside, passing motorists help deliver baby
  • Man remanded after wielding knife, trying to snatch baby in Penang supermarket
  • 2 Singapore drivers allegedly detained in Legoland for offering illegal ride-hailing services; cars seized
  • Vers likely to be launched in next decade: Chee Hong Tat
  • Malaysia's border control agency gives ICA cake to mark SG60
  • Tourist in Hong Kong killed after cabby, 80, crashes into pillar outside hotel
  • 2 Malaysian men nabbed at Woodlands Checkpoint for allegedly smuggling drugs worth over $150k into Singapore
This website is best viewed using the latest versions of web browsers.